{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,7]],"date-time":"2026-04-07T22:51:43Z","timestamp":1775602303138,"version":"3.50.1"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2020,7,15]],"date-time":"2020-07-15T00:00:00Z","timestamp":1594771200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,7,15]],"date-time":"2020-07-15T00:00:00Z","timestamp":1594771200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100008353","name":"Funda\u00e7\u00e3o de Apoio ao Ensino, Pesquisa e Assist\u00eancia do Hospital das Cl\u00ednicas da Faculdade de Medicina de Ribeir\u00e3o Preto da Universidade de S\u00e3o Paulo","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008353","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001807","name":"Funda\u00e7\u00e3o de Amparo \u00e0 Pesquisa do Estado de S\u00e3o Paulo","doi-asserted-by":"publisher","award":["14\/20341-0"],"award-info":[{"award-number":["14\/20341-0"]}],"id":[{"id":"10.13039\/501100001807","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003593","name":"Conselho Nacional de Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico","doi-asserted-by":"publisher","award":["457884\/2014-2"],"award-info":[{"award-number":["457884\/2014-2"]}],"id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Biol Rep"],"published-print":{"date-parts":[[2020,8]]},"DOI":"10.1007\/s11033-020-05655-5","type":"journal-article","created":{"date-parts":[[2020,7,15]],"date-time":"2020-07-15T18:03:41Z","timestamp":1594836221000},"page":"6439-6443","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Frequency of the TP53 p.R337H mutation in a Brazilian cohort of pediatric patients with solid tumors"],"prefix":"10.1007","volume":"47","author":[{"given":"Jos\u00e9 Antonio da Silva","family":"Feitosa","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pablo Ferreira","family":"das Chagas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Graziella Ribeiro","family":"de Sousa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rosane Gomes de Paula","family":"Queiroz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gustavo Alencastro Veiga","family":"Cruzeiro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luiz Gonzaga","family":"Tone","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0356-922X","authenticated-orcid":false,"given":"Kleiton Silva","family":"Borges","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elvis Terci","family":"Valera","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,7,15]]},"reference":[{"key":"5655_CR1","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21590","author":"RL Siegel","year":"2020","unstructured":"Siegel RL, Miller KD, Jemal A (2020) Cancer statistics, 2020. CA Cancer J Clin. https:\/\/doi.org\/10.3322\/caac.21590","journal-title":"CA Cancer J Clin"},{"key":"5655_CR2","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.14461","author":"JM Valdez","year":"2017","unstructured":"Valdez JM, Nichols KE, Kesserwan C (2017) Li\u2013Fraumeni syndrome: a paradigm for the understanding of hereditary cancer predisposition. Br J Haematol. https:\/\/doi.org\/10.1111\/bjh.14461","journal-title":"Br J Haematol"},{"key":"5655_CR3","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-17-0408","author":"CP Kratz","year":"2017","unstructured":"Kratz CP, Achatz MI, Brugieres L et al (2017) Cancer screening recommendations for individuals with Li\u2013Fraumeni syndrome. Clin Cancer Res. https:\/\/doi.org\/10.1158\/1078-0432.CCR-17-0408","journal-title":"Clin Cancer Res"},{"key":"5655_CR4","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2014.59.5728","author":"G Bougeard","year":"2015","unstructured":"Bougeard G, Renaux-Petel M, Flaman JM et al (2015) Revisiting Li\u2013Fraumeni syndrome from TP53 mutation carriers. J Clin Oncol. https:\/\/doi.org\/10.1200\/JCO.2014.59.5728","journal-title":"J Clin Oncol"},{"key":"5655_CR5","doi-asserted-by":"publisher","DOI":"10.4238\/2015.December.16.4","author":"LM Borges","year":"2015","unstructured":"Borges LM, Ayres FM (2015) R337H mutation of the TP53 gene as a clinical marker in cancer patients: a systematic review of literature. Genet Mol Res. https:\/\/doi.org\/10.4238\/2015.December.16.4","journal-title":"Genet Mol Res"},{"key":"5655_CR6","doi-asserted-by":"publisher","DOI":"10.1590\/1806-9282.61.03.282","author":"CR Giacomazzi","year":"2015","unstructured":"Giacomazzi CR, Giacomazzi J, Netto CBO et al (2015) Pediatric cancer and Li\u2013Fraumeni\/Li\u2013Fraumeni-like syndromes: a review for the pediatrician. Rev Assoc Med Bras. https:\/\/doi.org\/10.1590\/1806-9282.61.03.282","journal-title":"Rev Assoc Med Bras"},{"key":"5655_CR7","doi-asserted-by":"publisher","DOI":"10.1002\/humu.23656","author":"C Fortuno","year":"2018","unstructured":"Fortuno C, James PA, Spurdle AB (2018) Current review of TP53 pathogenic germline variants in breast cancer patients outside Li\u2013Fraumeni syndrome. Hum Mutat. https:\/\/doi.org\/10.1002\/humu.23656","journal-title":"Hum Mutat"},{"key":"5655_CR8","doi-asserted-by":"publisher","DOI":"10.2217\/fon-2016-0236","author":"M Guidi","year":"2017","unstructured":"Guidi M, Giunti L, Lucchesi M et al (2017) Brain tumors in Li\u2013Fraumeni syndrome: a commentary and a case of a gliosarcoma patient. Futur Oncol. https:\/\/doi.org\/10.2217\/fon-2016-0236","journal-title":"Futur Oncol"},{"key":"5655_CR9","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2019001407","author":"SS Khatri","year":"2019","unstructured":"Khatri SS, Kim AS (2019) Li\u2013Fraumeni syndrome presenting as precursor B lymphoblastic leukemia mimicking intravascular large B-cell lymphoma. Blood. https:\/\/doi.org\/10.1182\/blood.2019001407","journal-title":"Blood"},{"key":"5655_CR10","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-030-25905-1_9","author":"A Jouinot","year":"2019","unstructured":"Jouinot A, Bertherat J (2019) Diseases predisposing to adrenocortical malignancy (Li\u2013Fraumeni Syndrome, Beckwith\u2013Wiedemann Syndrome, and Carney Complex). Exp Suppl. https:\/\/doi.org\/10.1007\/978-3-030-25905-1_9","journal-title":"Exp Suppl"},{"key":"5655_CR11","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.24611","author":"T Tanaka","year":"2018","unstructured":"Tanaka T, Watanabe M, Yamashita K (2018) Potential therapeutic targets of TP53 gene in the context of its classically canonical functions and its latest non-canonical functions in human cancer. Oncotarget. https:\/\/doi.org\/10.18632\/oncotarget.24611","journal-title":"Oncotarget"},{"key":"5655_CR12","doi-asserted-by":"publisher","DOI":"10.1016\/j.jsbmb.2019.04.011","author":"AM Ferreira","year":"2019","unstructured":"Ferreira AM, Brondani VB, Helena VP et al (2019) Clinical spectrum of Li\u2013Fraumeni syndrome\/Li\u2013Fraumeni-like syndrome in Brazilian individuals with the TP53 p.R337H mutation. J Steroid Biochem Mol Biol. https:\/\/doi.org\/10.1016\/j.jsbmb.2019.04.011","journal-title":"J Steroid Biochem Mol Biol"},{"key":"5655_CR13","doi-asserted-by":"publisher","DOI":"10.1007\/s10689-017-0028-4","author":"GS Macedo","year":"2018","unstructured":"Macedo GS, Vieira IA, Vianna FSL et al (2018) p53 signaling pathway polymorphisms, cancer risk and tumor phenotype in TP53 R337H mutation carriers. Fam Cancer. https:\/\/doi.org\/10.1007\/s10689-017-0028-4","journal-title":"Fam Cancer"},{"key":"5655_CR14","doi-asserted-by":"publisher","DOI":"10.1038\/nsb730","author":"EL DiGiammarino","year":"2002","unstructured":"DiGiammarino EL, Lee AS, Cadwell C et al (2002) A novel mechanism of tumorigenesis involving pH-dependent destabilization of a mutant p53 tetramer. Nat Struct Biol. https:\/\/doi.org\/10.1038\/nsb730","journal-title":"Nat Struct Biol"},{"key":"5655_CR15","doi-asserted-by":"publisher","DOI":"10.1016\/j.jped.2017.06.009","author":"MJ Mastellaro","year":"2018","unstructured":"Mastellaro MJ, Ribeiro RC, Oliveira-Filho AG et al (2018) Adrenocortical tumors associated with the TP53 p.R337H germline mutation can be identified during child-care consultations. J Pediatr (Rio J). https:\/\/doi.org\/10.1016\/j.jped.2017.06.009","journal-title":"J Pediatr (Rio J)"},{"key":"5655_CR16","doi-asserted-by":"publisher","DOI":"10.1136\/jmg.2004.030551","author":"BC Figueiredo","year":"2006","unstructured":"Figueiredo BC, Sandrini R, Zambetti GP et al (2006) Penetrance of adrenocortical tumours associated with the germline TP53 R337H mutation. J Med Genet. https:\/\/doi.org\/10.1136\/jmg.2004.030551","journal-title":"J Med Genet"},{"key":"5655_CR17","first-page":"109","volume":"25","author":"EH Rozemuller","year":"2001","unstructured":"Rozemuller EH, Kropveld A, Kreyveld E et al (2001) Sensitive detection of p53 mutation: analysis by direct sequencing and multisequence analysis. Cancer Detect Prev 25:109\u2013116","journal-title":"Cancer Detect Prev"},{"key":"5655_CR18","doi-asserted-by":"publisher","first-page":"2927","DOI":"10.1200\/JCO.2012.48.5052","volume":"31","author":"N Zhukova","year":"2013","unstructured":"Zhukova N, Ramaswamy V, Remke M et al (2013) Subgroupspecific prognostic implications of TP53 mutation in medulloblastoma. J Clin Oncol 31:2927\u20132935","journal-title":"J Clin Oncol"},{"key":"5655_CR19","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2012.46.3711","author":"G Cust\u00f3dio","year":"2013","unstructured":"Cust\u00f3dio G, Parise GA, Kiesel Filho N et al (2013) Impact of neonatal screening and surveillance for the TP53 R337H mutation on early detection of childhood adrenocortical tumors. J Clin Oncol. https:\/\/doi.org\/10.1200\/JCO.2012.46.3711","journal-title":"J Clin Oncol"},{"key":"5655_CR20","doi-asserted-by":"publisher","DOI":"10.1016\/j.canep.2015.01.005","author":"EF de Legal","year":"2015","unstructured":"Legal EF de, Ascurra M, Cust\u00f3dio G et al (2015) Prevalence of an inherited cancer predisposition syndrome associated with the germ line TP53 R337H mutation in Paraguay. Cancer Epidemiol. https:\/\/doi.org\/10.1016\/j.canep.2015.01.005","journal-title":"Cancer Epidemiol"},{"key":"5655_CR21","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0018015","author":"G Custodio","year":"2011","unstructured":"Custodio G, Taques GR, Figueiredo BC et al (2011) Increased incidence of choroid plexus carcinoma due to the germline TP53 R337H mutation in southern Brazil. PLoS ONE. https:\/\/doi.org\/10.1371\/journal.pone.0018015","journal-title":"PLoS ONE"},{"key":"5655_CR22","doi-asserted-by":"publisher","DOI":"10.3390\/cancers12020506","author":"EM Pinto","year":"2020","unstructured":"Pinto EM, Faucz FR, Paza LZ et al (2020) Germline variants in phosphodiesterase genes and genetic predisposition to pediatric adrenocortical tumors. Cancers (Basel). https:\/\/doi.org\/10.3390\/cancers12020506","journal-title":"Cancers (Basel)"},{"key":"5655_CR23","doi-asserted-by":"publisher","DOI":"10.1200\/JOP.19.00201","author":"K DeLeonardis","year":"2019","unstructured":"DeLeonardis K, Hogan L, Cannistra SA, Rangachari D, Tung N (2019) When should tumor genomic profiling prompt consideration of germline testing? J Oncol Pract. https:\/\/doi.org\/10.1200\/JOP.19.00201","journal-title":"J Oncol Pract"},{"key":"5655_CR24","unstructured":"Aedma SK, Kasi A. Li\u2013Fraumeni Syndrome. [Updated 2020 May 22]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2020. Available from: https:\/\/doi.org\/https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK532286\/"},{"key":"5655_CR25","doi-asserted-by":"publisher","DOI":"10.1136\/jmg.38.1.43","author":"A Chompret","year":"2001","unstructured":"Chompret A, Abel A, Stoppa-Lyonnet D et al (2001) Sensitivity and predictive value of criteria for p53 germline mutation screening. J Med Genet. https:\/\/doi.org\/10.1136\/jmg.38.1.43","journal-title":"J Med Genet"},{"key":"5655_CR26","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.28507","author":"S Hettmer","year":"2014","unstructured":"Hettmer S, Archer NM, Somers GR et al (2014) Anaplastic rhabdomyosarcoma in TP53 germline mutation carriers. Cancer. https:\/\/doi.org\/10.1002\/cncr.28507","journal-title":"Cancer"},{"key":"5655_CR27","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-19-2631","author":"DL Casey","year":"2020","unstructured":"Casey DL, Wexler LH, Pitter KL, Samstein RM, Slotkin EK, Wolden SL (2020) Genomic determinants of clinical outcomes in rhabdomyosarcoma. Clin Cancer Res. https:\/\/doi.org\/10.1158\/1078-0432.CCR-19-2631","journal-title":"Clin Cancer Res"}],"container-title":["Molecular Biology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-020-05655-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11033-020-05655-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-020-05655-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,14]],"date-time":"2021-07-14T23:16:13Z","timestamp":1626304573000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11033-020-05655-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7,15]]},"references-count":27,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2020,8]]}},"alternative-id":["5655"],"URL":"https:\/\/doi.org\/10.1007\/s11033-020-05655-5","relation":{},"ISSN":["0301-4851","1573-4978"],"issn-type":[{"value":"0301-4851","type":"print"},{"value":"1573-4978","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,7,15]]},"assertion":[{"value":"13 April 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 July 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 July 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Parents gave written informed consent for genetic studies and for the publication of data (available upon request). This case report was also IRB approved by\u00a0The Ethics Committee in Human Research at Ribeir\u00e3o Preto General Hospital and Ribeir\u00e3o Preto Medical School (CAAE:09821219.0.0000.5440).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}